1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,760 | 4,600 | 10.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Dividendenbekanntmachungen (08.09.2025) | 4.760 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALPHABET INC CDR CA02080K1049 0,0341 CAD 0,0211 EUR ALPHABET INC CL A US02079K3059 0,21 USD 0,1791 EUR ALPHABET INC CL C US02079K1079 0... ► Artikel lesen | |
| Mo | Elekta Names Klara Eiritz Next CFO As Hägglöv Departs | 2 | RTTNews | ||
| 04.09. | Elekta AB: Report from the Annual General Meeting 2025 of Elekta | 145 | GlobeNewswire (Europe) | Elekta AB (publ) has held its Annual General Meeting on September 4, 2025. The statement at the Meeting from the President and CEO will be available on Elekta's website, www.elekta.com. Documents from... ► Artikel lesen | |
| 03.09. | UBS initiates Elekta at "sell," cites slowing radiotherapy market and 30% downside | 3 | Investing.com | ||
| 03.09. | UBS initiates Elekta stock with Sell rating, citing market headwinds | 1 | Investing.com | ||
| 28.08. | Elekta AB: Interim report, First quarter May-July 2025/26 | 185 | GlobeNewswire (Europe) | First quarterIn constant exchange rates, net sales increased by 3 percent driven by Europe. Reported sales in SEK decreased by 5 percent amounting to SEK 3,646 M (3,825).Book-to-bill ratio of 1.05 (1.10)... ► Artikel lesen | |
| 29.07. | S&P revises Elekta AB outlook to negative amid elevated leverage | 32 | Investing.com | ||
| 23.07. | Elekta wins expanded FDA nod for Gamma Knife radiosurgery system | 4 | MassDevice | ||
| ELEKTA AB ADR Aktie jetzt für 0€ handeln | |||||
| 23.07. | Elekta's Gamma Knife Gains FDA Clearance For Drug-Resistant Temporal Lobe Epilepsy | 1 | RTTNews | ||
| 23.07. | Elekta AB: Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | 151 | GlobeNewswire (Europe) | New indication expands treatment options for neurosurgeons managing complex epilepsy cases
ATLANTA - Elekta (EKTA-B.ST) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k)... ► Artikel lesen | |
| 11.06. | Citi bekräftigt Verkaufsempfehlung für Elekta-Aktie | 36 | Investing.com Deutsch | ||
| 11.06. | CITI REITERATES SELL RATING ON ELEKTA STOCK AMID PRICING SHIFT | 9 | Investing.com | ||
| 10.06. | Elekta shares down after SEK 4.9 bln order cancellation; new CEO appointed | 21 | Investing.com | ||
| 09.06. | Elekta announces a new CEO | 10 | MassDevice | ||
| 09.06. | Elekta AB: Elekta appoints Jakob Just-Bomholt as new President and CEO | 263 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today the appointment by the Board of Directors of Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
Jakob, a... ► Artikel lesen | |
| 28.05. | Elekta AB GAAP EPS of -SEK 1.01, revenue of SEK 5.16B; initiates Q1 outlook | 18 | Seeking Alpha | ||
| 28.05. | Elekta AB: Year-end report May-April 2024/25 | 301 | GlobeNewswire (Europe) | Fourth quarterIn constant exchange rates, net sales increased by 6 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 5,156 M (5,023).Book-to-bill ratio... ► Artikel lesen | |
| 03.05. | Elekta AB: Clinical trial shows more precise radiotherapy using Elekta Unity MR-Linac preserves sexual function in men with prostate cancer | 213 | GlobeNewswire (Europe) | ERECT trial used MR-guidance to spare nerves and blood vessels essential for achieving and maintaining an erection
VIENNA - Elekta (EKTA-B.ST) today announced that use of its 1.5T Elekta Unity MR-Linac... ► Artikel lesen | |
| 07.03. | Dividendenbekanntmachungen (07.03.2025) | 18.882 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2177 EUR AEW UK REIT PLC GB00BWD24154 0,02 GBP EUR AMERISAFE INC US03071H1005 0... ► Artikel lesen | |
| 26.02. | Elekta AB: Gustaf Salford to leave position as President and CEO of Elekta as of March 6 | 460 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today that Gustaf Salford, President and CEO, and the Board of Directors, have decided that Gustaf will leave Elekta as of March 6. Jonas Bolander, Executive... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FAMICORD | 6,800 | +1,49 % | Original-Research: FamiCord AG (von Montega AG): Halten (zuvor: Kaufen) | Original-Research: FamiCord AG - von Montega AG
03.09.2025 / 10:03 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| SPINEWAY | 0,117 | -2,66 % | Spineway: H1 2025 results - Continued improvement in results and financial position | Press release Ecully, July 30, 2025 - 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of... ► Artikel lesen | |
| PETMED EXPRESS | 2,375 | 0,00 % | PetMed Express Receives Nasdaq Notice Over Late Annual Report Filing | WASHINGTON (dpa-AFX) - PetMed Express, Inc. (PETS) announced that it received a notice from Nasdaq on July 2, 2025, stating the company is not in compliance with Nasdaq Listing Rule 5250(c)(1)... ► Artikel lesen | |
| QUIDELORTHO | 24,600 | +3,36 % | QuidelOrtho Corporation: QuidelOrtho Completes Debt Refinancing | SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic... ► Artikel lesen | |
| ELEKTA | 4,236 | +0,43 % | Dividendenbekanntmachungen (05.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAON INC US0003602069 0,1 USD 0,0858 EUR ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2017 EUR AIA GROUP LTD HK0000069689 0... ► Artikel lesen | |
| STAAR SURGICAL | 23,730 | +0,34 % | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025 | ||
| TELEFLEX | 112,00 | 0,00 % | Dividendenbekanntmachungen (15.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,06 USD 0,0514 EUR AGCO CORPORATION US0010841023 0,29 USD 0,2489 EUR ALBEMARLE CORPORATION PREF... ► Artikel lesen | |
| NOVACYT | 0,449 | -5,87 % | Novacyt S.A. - Liquidity Agreement Monthly Update and TVR | ||
| M3 INC | 13,800 | +3,76 % | Deutliches Plus erfreut Inhaber der M3-Aktie (12,50 €) | Grund zur Freude haben Aktionäre von M3 : Das Papier steigt deutlich. Zu den stärksten Werten des Tages gehört heute der Anteilsschein von M3 mit einem Wertanstieg von 11,61 Prozent. Für das Papier... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 67,20 | -0,21 % | Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer | MINNEAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally... ► Artikel lesen | |
| AMBEA | 12,200 | -0,16 % | Ambea AB: Ambea's interim report April - June 2025 | strong>Higher growth rate and earnings
CEO comments:
We reported a strong trend during the quarter, with clear growth in sales and earnings. A significant part of this growth was driven by Validia... ► Artikel lesen | |
| SHIP HEALTHCARE | 13,200 | +1,54 % | Ship Healthcare im Geschäftsjahr 2025: Umsatz steigt um 7,5 %, Strategieplan "SHIP VISION 2030" vorgestellt | ||
| BUMRUNGRAD HOSPITAL | 4,900 | 0,00 % | Dividendenbekanntmachungen (19.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALL FOR ONE GROUP SE DE0005110001 - 1,6 EUR AP MOELLER-MAERSK A/S A DK0010244425 1120 DKK 150,155 EUR AP MOELLER-MAERSK A/S B DK0010244508 1120... ► Artikel lesen | |
| MERCATOR MEDICAL | 10,060 | +0,20 % | Mercator Medical wants to buy back up to 124,000 of its own shares | ||
| SIEMENS HEALTHINEERS | 48,280 | +2,20 % | Siemens Healthineers: Die Langeweile setzt sich fort! |
Das Unternehmen ELEKTA AB ADR kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 4,120 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ELEKTA AB ADR finden Sie auf Wallstreet Online.